• Innovex priced an underwritten secondary offering of 5,000,000 common shares sold by affiliates of Amberjack Capital Partners.
• No shares are being sold by the company; no proceeds will be received.
• Barclays is sole underwriter; closing expected Aug. 10, 2026, subject to customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innovex International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260806645782) on August 07, 2026, and is solely responsible for the information contained therein.